Updates are available Correction dated 2024-01-09
Click to view Correction: https://doi.org/10.1038/s41591-024-02799-w
-
Authors
Heczey, Andras https://orcid.org/0000-0002-4263-9115
Xu, Xin https://orcid.org/0000-0002-9485-8782
Courtney, Amy N. https://orcid.org/0000-0001-7013-3042
Tian, Gengwen
Barragan, Gabriel A.
Guo, Linjie
Amador, Claudia Martinez https://orcid.org/0000-0002-3933-7300
Ghatwai, Nisha
Rathi, Purva
Wood, Michael S.
Li, Yanchuan
Zhang, Chunchao
Demberg, Thorsten
Di Pierro, Erica J.
Sher, Andrew C.
Zhang, Huimin
Mehta, Birju
Thakkar, Sachin G. https://orcid.org/0000-0002-7077-4971
Grilley, Bambi
Wang, Tao https://orcid.org/0000-0003-1957-7160
Weiss, Brian D. https://orcid.org/0000-0001-5154-3134
Montalbano, Antonino
Subramaniam, Meena
Xu, Chenling
Sachar, Chirag
Wells, Daniel K. https://orcid.org/0000-0003-2463-3139
Dotti, Gianpietro
Metelitsa, Leonid S. https://orcid.org/0000-0002-9639-6630
-
Funding
Funding for this research was provided by:
Alex’s Lemonade Stand Foundation for Childhood Cancer
St. Baldrick’s Foundation
American Cancer Society
Texas Children’s Hospital
Athenex, Inc.
Baylor College of Medicine
Cincinnati Children’s Hospital Medical Center
Immunai, Inc
Immunai, Inc.
UNC | UNC-Chapel Hill | Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
- License Information
-
More Information
Article History
Received: 23 August 2022
Accepted: 24 April 2023
First Online: 15 May 2023
Change Date: 9 January 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41591-024-02799-w
Competing interests
: A.H., A.N.C., G.T., X.X, G.D. and L.S.M. are co-inventors on pending patent applications that relate to the use of NKTs in cancer immunotherapy, including those that have been licensed by Baylor College of Medicine to Athenex, Inc. for commercial development. Athenex, Inc. provided research support for this project (to L.S.M.) via a sponsored research agreement with Baylor College of Medicine. G.A.B., L.G., C.M.A., N.G., P.R., M.S.W., Y.L., C.Z., T.D., E.J.D.P., A.C.S., H.Z., B.M., S.G.T., B.G., T.W., B.D.W., A.M., M.S., C.X., C.S. and D.K.W. declare no competing financial interests.
